Cargando…

Development of a quantitative segmentation model to assess the effect of comorbidity on patients with COVID-19

BACKGROUND: The coronavirus disease 2019 (COVID-19) has brought a global disaster. Quantitative lesions may provide the radiological evidence of the severity of pneumonia and further to assess the effect of comorbidity on patients with COVID-19. METHODS: 294 patients with COVID-19 were enrolled from...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Cui, Yang, Guangzhao, Cai, Chunxian, Xu, Zhihua, Wu, Hai, Guo, Youmin, Xie, Zongyu, Shi, Hengfeng, Cheng, Guohua, Wang, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7549080/
https://www.ncbi.nlm.nih.gov/pubmed/33046116
http://dx.doi.org/10.1186/s40001-020-00450-1
_version_ 1783592735523995648
author Zhang, Cui
Yang, Guangzhao
Cai, Chunxian
Xu, Zhihua
Wu, Hai
Guo, Youmin
Xie, Zongyu
Shi, Hengfeng
Cheng, Guohua
Wang, Jian
author_facet Zhang, Cui
Yang, Guangzhao
Cai, Chunxian
Xu, Zhihua
Wu, Hai
Guo, Youmin
Xie, Zongyu
Shi, Hengfeng
Cheng, Guohua
Wang, Jian
author_sort Zhang, Cui
collection PubMed
description BACKGROUND: The coronavirus disease 2019 (COVID-19) has brought a global disaster. Quantitative lesions may provide the radiological evidence of the severity of pneumonia and further to assess the effect of comorbidity on patients with COVID-19. METHODS: 294 patients with COVID-19 were enrolled from February, 24, 2020 to June, 1, 2020 from six centers. Multi-task Unet network was used to segment the whole lung and lesions from chest CT images. This deep learning method was pre-trained in 650 CT images (550 in primary dataset and 100 in test dataset) with COVID-19 or community-acquired pneumonia and Dice coefficients in test dataset were calculated. 50 CT scans of 50 patients (15 with comorbidity and 35 without comorbidity) were random selected to mark lesions manually. The results will be compared with the automatic segmentation model. Eight quantitative parameters were calculated based on the segmentation results to evaluate the effect of comorbidity on patients with COVID-19. RESULTS: Quantitative segmentation model was proved to be effective and accurate with all Dice coefficients more than 0.85 and all accuracies more than 0.95. Of the 294 patients, 52 (17.7%) patients were reported having at least one comorbidity; 14 (4.8%) having more than one comorbidity. Patients with any comorbidity were older (P < 0.001), had longer incubation period (P < 0.001), were more likely to have abnormal laboratory findings (P < 0.05), and be in severity status (P < 0.001). More lesions (including larger volume of lesion, consolidation, and ground-glass opacity) were shown in patients with any comorbidity than patients without comorbidity (all P < 0.001). More lesions were found on CT images in patients with more comorbidities. The median volumes of lesion, consolidation, and ground-glass opacity in diabetes mellitus group were largest among the groups with single comorbidity that had the incidence rate of top three. CONCLUSIONS: Multi-task Unet network can make quantitative CT analysis of lesions to assess the effect of comorbidity on patients with COVID-19, further to provide the radiological evidence of the severity of pneumonia. More lesions (including GGO and consolidation) were found in CT images of cases with comorbidity. The more comorbidities patients have, the more lesions CT images show.
format Online
Article
Text
id pubmed-7549080
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-75490802020-10-13 Development of a quantitative segmentation model to assess the effect of comorbidity on patients with COVID-19 Zhang, Cui Yang, Guangzhao Cai, Chunxian Xu, Zhihua Wu, Hai Guo, Youmin Xie, Zongyu Shi, Hengfeng Cheng, Guohua Wang, Jian Eur J Med Res Research BACKGROUND: The coronavirus disease 2019 (COVID-19) has brought a global disaster. Quantitative lesions may provide the radiological evidence of the severity of pneumonia and further to assess the effect of comorbidity on patients with COVID-19. METHODS: 294 patients with COVID-19 were enrolled from February, 24, 2020 to June, 1, 2020 from six centers. Multi-task Unet network was used to segment the whole lung and lesions from chest CT images. This deep learning method was pre-trained in 650 CT images (550 in primary dataset and 100 in test dataset) with COVID-19 or community-acquired pneumonia and Dice coefficients in test dataset were calculated. 50 CT scans of 50 patients (15 with comorbidity and 35 without comorbidity) were random selected to mark lesions manually. The results will be compared with the automatic segmentation model. Eight quantitative parameters were calculated based on the segmentation results to evaluate the effect of comorbidity on patients with COVID-19. RESULTS: Quantitative segmentation model was proved to be effective and accurate with all Dice coefficients more than 0.85 and all accuracies more than 0.95. Of the 294 patients, 52 (17.7%) patients were reported having at least one comorbidity; 14 (4.8%) having more than one comorbidity. Patients with any comorbidity were older (P < 0.001), had longer incubation period (P < 0.001), were more likely to have abnormal laboratory findings (P < 0.05), and be in severity status (P < 0.001). More lesions (including larger volume of lesion, consolidation, and ground-glass opacity) were shown in patients with any comorbidity than patients without comorbidity (all P < 0.001). More lesions were found on CT images in patients with more comorbidities. The median volumes of lesion, consolidation, and ground-glass opacity in diabetes mellitus group were largest among the groups with single comorbidity that had the incidence rate of top three. CONCLUSIONS: Multi-task Unet network can make quantitative CT analysis of lesions to assess the effect of comorbidity on patients with COVID-19, further to provide the radiological evidence of the severity of pneumonia. More lesions (including GGO and consolidation) were found in CT images of cases with comorbidity. The more comorbidities patients have, the more lesions CT images show. BioMed Central 2020-10-12 /pmc/articles/PMC7549080/ /pubmed/33046116 http://dx.doi.org/10.1186/s40001-020-00450-1 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Zhang, Cui
Yang, Guangzhao
Cai, Chunxian
Xu, Zhihua
Wu, Hai
Guo, Youmin
Xie, Zongyu
Shi, Hengfeng
Cheng, Guohua
Wang, Jian
Development of a quantitative segmentation model to assess the effect of comorbidity on patients with COVID-19
title Development of a quantitative segmentation model to assess the effect of comorbidity on patients with COVID-19
title_full Development of a quantitative segmentation model to assess the effect of comorbidity on patients with COVID-19
title_fullStr Development of a quantitative segmentation model to assess the effect of comorbidity on patients with COVID-19
title_full_unstemmed Development of a quantitative segmentation model to assess the effect of comorbidity on patients with COVID-19
title_short Development of a quantitative segmentation model to assess the effect of comorbidity on patients with COVID-19
title_sort development of a quantitative segmentation model to assess the effect of comorbidity on patients with covid-19
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7549080/
https://www.ncbi.nlm.nih.gov/pubmed/33046116
http://dx.doi.org/10.1186/s40001-020-00450-1
work_keys_str_mv AT zhangcui developmentofaquantitativesegmentationmodeltoassesstheeffectofcomorbidityonpatientswithcovid19
AT yangguangzhao developmentofaquantitativesegmentationmodeltoassesstheeffectofcomorbidityonpatientswithcovid19
AT caichunxian developmentofaquantitativesegmentationmodeltoassesstheeffectofcomorbidityonpatientswithcovid19
AT xuzhihua developmentofaquantitativesegmentationmodeltoassesstheeffectofcomorbidityonpatientswithcovid19
AT wuhai developmentofaquantitativesegmentationmodeltoassesstheeffectofcomorbidityonpatientswithcovid19
AT guoyoumin developmentofaquantitativesegmentationmodeltoassesstheeffectofcomorbidityonpatientswithcovid19
AT xiezongyu developmentofaquantitativesegmentationmodeltoassesstheeffectofcomorbidityonpatientswithcovid19
AT shihengfeng developmentofaquantitativesegmentationmodeltoassesstheeffectofcomorbidityonpatientswithcovid19
AT chengguohua developmentofaquantitativesegmentationmodeltoassesstheeffectofcomorbidityonpatientswithcovid19
AT wangjian developmentofaquantitativesegmentationmodeltoassesstheeffectofcomorbidityonpatientswithcovid19